Cornell Cancer & Oncology Research
80 recent oncology and cancer research papers authored by Cornell University faculty and affiliates, drawn from arXiv, newest first.
80 listed
-
629 Targeting ENT1 enhances tumor immunogenicity and overcomes resistance to immune checkpoint blockade2026-11-01Taha Merghoub
-
428 Targeting CXCR2 abrogates resistance to immune checkpoint blockade in Lkb1-mutant lung cancer via neutrophil reprogramming2026-11-01Taha Merghoub
-
630 Metformin and phenformin differentially modulate the tumor immune microenvironment and response to immune checkpoint blockadessss2026-11-01Sadna Budhu, Taha Merghoub
-
1001 Pathogenic neutrophil recruitment and activation drive cutaneous toxicity during T cell immunotherapy2026-11-01Sadna Budhu, Taha Merghoub
-
941 Enzyme-secreting CAR-T cells remodel the cancer glycocalyx to overcome mucin-mediated resistance in solid tumors2026-11-01Justin H. Paek
-
378 Myeloid checkpoint blockade potentiates the antitumor activity of radiotherapy by limiting TR-CCR7hi DCs dendritic cell–mediated treg recruitment2026-11-01Maud Charpentier, Alicia Alonso, Maider Astorkia Amiama, Sandra Demaria
-
15 Predicting immunotherapy response ex vivo : clinical validation of the E-slice assay in TNBC patients in a prospective clinical study2026-11-01Kyuson Yun
-
329 Enhancing the efficacy of tumor infiltrating lymphocyte (TIL) therapy2026-11-01Sadna Budhu, Jonathan F. Khan, Taha Merghoub
-
1077 Defining immune selection-driven neoantigen evolution to optimize cancer vaccine targets2026-11-01Mariam Mathew George, Taha Merghoub
-
T Cell Receptor–Engineered T Cell Therapy in Solid Tumors: Where We Stand and What's to Come2026-10-23Sandra P. D’Angelo
-
Employment after curative breast cancer treatment: the breast cancer and the workforce cohort study2026-10-23Manmeet Malik
-
Preoperative gemcitabine versus 5-FU–based chemotherapy: is there a standard of care?2026-10-23David H. Ilson
-
Recent trends in race and ethnicity reporting in breast surgery journals2026-10-23Tammy Ju
-
Lower airway microbiome transcriptional and metabolic activities influence responsiveness to immunotherapy in NSCLC2026-10-21Ezequiel Dantas
-
Locoregionally delivered PD-1 blockade augments B7-H3 targeting CAR T cell efficacy in models of glioblastoma2026-10-13Jonathan F. Khan, Parwiz Abrahimi, Lauren Dong, Svena Verma, Yacine Marouf, Sadna Budhu, Tara Pal Chaudhuri, Valeria Estrada Navarro, Mamadou A. Bah, Kelsey Hop
-
Combating CD24 to overcome CD19 CAR-T resistance via induction of innate and adaptive immunity in B-cell malignancies2026-10-12Xiangao Huang, Selina Chen‐Kiang
-
Patient experiences and unmet needs in diagnosis and treatment of metastatic colorectal cancer: results of a US survey2026-10-10Manish Bikram Shah
-
COVID-19 Vaccination Around ICI Initiation and Survival in Lung, Kidney, and Melanoma2026-10-08Chen Lyu, Mila Sun, Paul B. Chapman, Jedd D. Wolchok
-
Exercise therapy in cancer prevention and treatment2026-10-07Joshua W. Bliss
-
A 3D Lymphatics-on-a-Chip Reveals Matrix Stiffness Dependent VEGFR-2 and VEGFR-3 Contributions to Lymphangiogenesis2026-10-01Lauren C. Richardson, Issahy Cano, Anna M. Kolarzyk, Esak Lee
-
Lymphatic constraint of germinal centers optimizes protective antibody responses2026-10-01Andrew David Miller
-
A noncanonical function of the tyrosine degradation enzyme FAH drives CDK4/6 inhibitor resistance in breast cancer2026-09-30Laura C. Collins
-
Comparative Effectiveness and Safety of FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Metastatic Colorectal Cancer: A GRADE-assessed Systematic Review and Meta-analysis2026-09-30Zaheer Qureshi
-
Implementation and evaluation of the Routine Assessment and Integration of Screening for Employment (RAISE) program in adults with metastatic breast cancer2026-09-30Laura C. Pinheiro, Z. Hamilton
-
Ursodeoxycholic Acid Oral Pharmacokinetics and Plasma Bile Acid Profile Changes in a Population of Healthy Neonatal Foals2026-09-28T. N. Burdette, Barbara Delvescovo, E. Wise Bellin, T. J. Divers, Callum George Donnelly
-
Developing cancer-control policies to address the cancer burden among young adults2026-09-24Saleh A. Alqahtani
-
Lifestyle Factors Associated With Colorectal Adenomas: Results From a Vietnamese Case–Control Study2026-09-24Hung Nguyen Luu
-
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab2026-09-23Amy Chadburn
-
Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy2026-09-23Jennifer Claytor, Erika Patel, Benjamin Gordon, Randy S. Longman
-
Beyond Corticosteroid Duration: Drug-Specific Pneumonitis Risk Should Inform Management of Immune Checkpoint Inhibitor Pneumonitis2026-09-23Mohammed I Danjuma
-
Prospective Observational Study of Post Surgical Pain in Women undergoing Mastectomy Surgery: Post Surgical Pain After Mastectomy (PPAM) Study2026-09-21Uchenna O. Umeh
-
An Integrated Workflow for Culturing and AI-Based Profiling of Mouse Intestinal Epithelium2026-09-20U Kaicheng
-
Sequencing analysis reveals evidence of immune activation in advanced HER2 negative breast cancer responders treated with the combination of entinostat, nivolumab, and ipilimumab2026-09-19Vered Stearns
-
NALIRIFOX versus FOLFIRINOX: reconstructed individual patient data meta-analysis of efficacy and safety in first-line treatment of unresectable or metastatic pancreatic ductal adenocarcinoma2026-09-18Abdullah Esmail, Jian Guan, Maen Abdelrahim
-
Balancing immunosuppression and cancer survival in the treatment of immune checkpoint inhibitor–associated inflammatory arthritis2026-09-18Anne R. Bass
-
Neoantigen-reactive CD8+ T cell engagement marks exceptional survivors of pancreatic cancer2026-09-18Joshua D. Schoenfeld, Michael May, Fiyinfolu Balogun, Kenneth H. Yu, Benoı̂t Rousseau, Yohyoh Wang, Jayon Lihm, Vineet Rolston, Vinod Balachandran, Christine Ia
-
Pancreatic Cancer Screening and Early Detection: Where Are We Now?2026-09-17Elizabeth M. Hecht
-
Epidemiology of respiratory viral infections among hematopoietic cellular therapy and chimeric antigen receptor T-cell therapy recipients in the post COVID-19 era2026-09-17Zainab Shahid, Miguel-Angel Perales, Mini Kamboj
-
Dendritic cell PD-L2 restrains intratumoral CD8 + T cell immunity2026-09-16Michael A. Postow, Chrysothemis C. Brown
-
Metabolic profiling of CAR T-cells in patients reveals a shift toward amino acid-supported OXPHOS and informs transporter engineering2026-09-15Mehdi Benzaoui
-
Top advances of the year in autologous cellular therapy in melanoma and solid tumors2026-09-14Kimberly Loo
-
PAIR-Scan: Single-step identification of highly potent TCR–neoantigen pairs through library-on-library screening2026-09-14Jani Huuhtanen
-
Longitudinal Relationship Between Physical Activity And Physical Function: Thinking And Living With Cancer Study2026-09-14Eunji Choi
-
Barriers and Blueprints: Next-Generation Engineering Strategies for CAR-T Cell Therapy in Gastrointestinal Tumors2026-09-12Abdullah Esmail
-
Spatial statistics infer structured immune signatures in primary prostate cancer2026-09-11Fabio Socciarelli
-
Neoadjuvant chemotherapy induces transient, regimen-specific immune stromal reprogramming in pancreatic ductal adenocarcinoma2026-09-11Eileen M. O’Reilly
-
Response shift in oncology: fact or myth2026-09-10Emma Wagman
-
ERBB2 Activating Mutations Promote Enhanced Internalization and Activity of Trastuzumab Deruxtecan in HER2-non-amplified Metastatic Breast Cancer2026-09-09Wanyi Chen
-
Impact of patient ancestry on melanoma immunotherapy immune-related adverse events2026-09-09Chen Lyu, Judy Zhong
-
Mohs Micrographic Surgery for Cutaneous Metastasis of Endometrial Carcinoma2026-09-08Benjamin Shtaynberger, J Lévy
-
Intravital single-cell behavior profiling reveals disrupted germinal center B cell motility and interactions by EZH2 gain-of-function mutation2026-09-06Xi Chen, Chris Xu
-
Low Rates of Discontinuation Unrelated to Disease Progression with Trastuzumab Deruxtecan in Metastatic Breast Cancer: A Real-World Study2026-09-06Carlo Bosi
-
The Global Immune–Nutrition–Inflammation Index (GINI) as a Candidate Prognostic Marker in Patients with Cutaneous Squamous Cell Carcinoma Treated with Cemiplimab2026-09-04Aviram Mizrachi
-
Truncated ErbB2 receptor expression lowers nucleus stiffness and increases migration of breast cancer cells2026-09-02Margaret A. Elpers
-
When Historical Housing Policy Shapes Modern Breast Cancer Prevention2026-09-02Laura C. Pinheiro
-
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia, version 2.02026-09-01Mónica L. Guzmán, Miguel‐Angel Perales
-
Patient-Friendly Summary of the ACR Appropriateness Criteria®: Staging and Follow-up of Melanoma2026-09-01Name: Kristen Coffey
-
New Paradigms in the Management of Castleman Disease2026-09-01Ariela Noy
-
SCLC TumorMiner: A genomics platform for small cell lung cancer precision oncology2026-09-01Anisha Tehim
-
A Phase I Study of Nab-Paclitaxel, Gemcitabine and AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas: ECOG-ACRIN EA21312026-09-01Neal J. Meropol
-
The changing therapeutic landscape of small-cell lung cancer2026-09-01Charles M Rudin
-
ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy2026-09-01Miguel‐Angel Perales
-
A Phase II Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 -Amplified Cancers: A Nonrandomized Clinical Trial2026-08-27Jessica C. Stuart, Winston Wong, David B. Solit, Mark Yungjie Jeng, Charles Hsu, Alexander Edward Dela Cruz Drilon, Vicky Makker, Gopa Iyer, Rona D. Yaeger, Gre
-
Multimodal Machine Learning for Predicting Outcomes in the PASS-01 Trial of Systemic Therapy for Metastatic Pancreatic Cancer2026-08-27K. Yu, Eileen M. O'Reilly
-
Generation of an induced pluripotent stem cell line from a patient with immune checkpoint inhibitor-induced myocarditis and concurrent type I diabetes2026-08-27Yuhsin Vivian Huang
-
Biopsied Cutaneous Adverse Effects of PD-1 and PD-L1 Checkpoint Inhibitors and Progression-free Survival: A Retrospective Case Series of 75 Patients2026-08-27Julian Willett
-
Neoadjuvant Botensilimab/Balstilimab for localized mismatch repair proficient and deficient colon cancer: Results of the NEST phase 2 clinical trial2026-08-26Manish A. Shah, Erika Hissong, Mehraneh D. Jafari, Maider Astorkia, Sahrish Khan, Casey Owens, Zhengming Chen, Heather Yeo, Fabio Socciarelli, Sandipto Sarkar,
-
Endothelial glycocalyx glycan expression in lymphatic vasculature in mice2026-08-26Issahy Cano, Esak Lee
-
Outpatient Treatment-Related Toxicity After Hospital Discharge Among Patients Receiving Lifileucel for Advanced Melanoma2026-08-25Mia Andreoli, Michael A. Postow, Jae H. Park, Charlotte E. Ariyan, Alexander N. Shoushtari, James W. Smithy
-
CellCage™ Technology Enables High-throughput Isolation of Defined Cell Combinations to Resolve the Determinants of CAR-T mediated Cytotoxicity2026-08-25Christopher E. Mason
-
Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group2026-08-24Sandra Demaria, Silvia C. Formenti
-
Optimizing methods to detect colonization with fluoroquinolone-resistant viridans group streptococci prior to hematopoietic cell transplantation2026-08-21Supram Hosuru Subramanya, Lee Gottesdiener, Jamie Marino, Juliet Barker, Tsiporah Shore, Rosemary Soave, Markus Plate, John R. Lee, Laura B. Goodman, Casey L. C
-
MetaFemina: development and evaluation of a large language model-assisted platform for automated meta-analysis of nutritional exposures and breast, ovarian, and uterine cancer risk2026-08-21Rulla Tamimi, Saurabh Mehta, Eunji Choi, Zhang Yongxian, Yushu Shi
-
Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives2026-08-21Michael May
-
Attention U-Net-Based Segmentation and Hybrid Classification for Detection of Circulating Tumor-Associated Cells2026-08-20Massimo Cristofanilli
-
Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework2026-08-18Scott T. Tagawa
-
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.22026-08-17Manish A. Shah
-
A NON-CANONICAL ROLE FOR NOTCH3 IN BUILDING THE INTESTINAL LYMPHATIC NICHE2026-08-15Natasza A. Kurpios, Liqing Huang, Bhargav D. Sanketi, Madhav Mantri, YanXi Chen, Clare Wang, Tristan Tran, Iwijn De Vlaminck
-
Advancing equitable breast cancer screening: the role of patient-centered education, community outreach, and accessible care pathways2026-08-14Shalinie Mahadeo, Katerina Dodelzon, Marina Corines
-
BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies2026-08-14Mrinal M. Gounder